Literature DB >> 25070238

Functional characterization of platelets in patients with arterial erectile dysfunction.

S La Vignera1, R A Condorelli, G Burgio, E Vicari, V Favilla, G I Russo, S Cimino, G Morgia, A E Calogero.   

Abstract

Arterial erectile dysfunction (ED) is commonly associated with classic cardiovascular and metabolic risk factors, such as smoking, hypertension, diabetes mellitus, dyslipidaemia and obesity. However, some patients with arterial ED do not present any cardiovascular risk factor. As mean platelet volume (MPV) has been shown to be directly related to the cardiovascular risk and the percentage of platelets expressing the vitronectin receptor (αVβ3), involved in the early stages of platelet adhesion, is higher in patients with ED, the present study was undertaken to evaluate MPV and αVβ3 in 15 patients with arterial ED not associated with any cardiovascular risk factor. Their MPV and αVβ3 values were compared with those of men with normal penile haemodynamic. Patients with arterial ED had a mean value of MPV (11.25 vs. 9.88 fL; p < 0.001) and a percentage of platelets expressing the αVβ3 (7.39 vs. 2.07%; p < 0.001) significantly higher compared to controls. A negative correlation was observed between peak systolic velocity and MPV (r = 0.916; p < 0.001) or αVβ3 (r = 0.930; p < 0.001), whereas MPV and αVβ3 correlated positively (r = 0.908; p < 0.001). In conclusion, this study showed for the first time that MPV and the percentage of platelet expressing αVβ3 are significantly higher in patients with arterial ED compared to controls. We speculate that these parameters of platelet function may be envisaged as markers of cardiovascular risk in patients with arterial ED.
© 2014 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  erectile dysfunction; mean platelet volume; penile Doppler; vitronectin receptor

Mesh:

Substances:

Year:  2014        PMID: 25070238     DOI: 10.1111/j.2047-2927.2014.00255.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  6 in total

1.  Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2019-06-22       Impact factor: 2.370

2.  Arterial erectile dysfunction is an early sign of vascular damage: the importance for the prevention of cardiovascular health.

Authors:  Sandro La Vignera; Rosita A Condorelli; Rossella Cannarella; Filippo Giacone; Aldo E Calogero
Journal:  Ann Transl Med       Date:  2019-07

3.  Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

4.  Is There a Role for Levo-Thyroxine for the Treatment of Arterial Erectile Dysfunction? The Clinical Relevance of the Mean Platelet Volume.

Authors:  Rossella Cannarella; Aldo E Calogero; Antonio Aversa; Rosita A Condorelli; Sandro La Vignera
Journal:  J Clin Med       Date:  2020-03-10       Impact factor: 4.241

5.  The Association Between FGF21 and Diabetic Erectile Dysfunction: Evidence from Clinical and Animal Studies.

Authors:  Song Yang; Yichun Zhang; Xiaohui Lyu; Yuanyuan Gu; Guodong Zhang; Pengcheng Liu; Yulu Zheng; Zheng Guo; Yanbo Zhang; Haifeng Hou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

6.  Mean Platelet Volume is Reduced in Acute Appendicitis.

Authors:  Egemen Kucuk; Irfan Kucuk
Journal:  Turk J Emerg Med       Date:  2016-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.